Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

 
<< vorige   
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1491 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1001 Portal and verification imaging of electron beams by digital storage phosphor radiography Zimmermann, J.S.
 1997
 33 S8 p. S104-S105
2 p.
 artikel
1002 Port-Systems in children with malignancies; Our experience with 111 children under cancer management Reddemann, H.
 1997
 33 S8 p. S127-
1 p.
 artikel
1003 Positron emission tomography (PET) and single photon emission tomography (SPET): Biological characterization of soft-tissue sarcoma. Preliminary results Schwarzbach, M.
 1997
 33 S8 p. S110-
1 p.
 artikel
1004 Positron emission tomography (PET): Diagnostic benefit in pancreatic tumors? Staib, L.
 1997
 33 S8 p. S274-
1 p.
 artikel
1005 Possibilities of gene therapy and radiotherapy Bourhis, Jean
 1997
 33 S8 p. S138-
1 p.
 artikel
1006 Possible negative impact on survival of too short an interval between surgery and postoperative radiotherapy in NSCLC Würschmidt, Florian
 1997
 33 S8 p. S227-
1 p.
 artikel
1007 Post operative high dose conformal radiation therapy with multileaf collimator for non small cell lung cancer (NSCLC) Vuillermoz, S.
 1997
 33 S8 p. S233-
1 p.
 artikel
1008 Postoperative radiotherapy for cervical carcinoma stage lb and lla with positive lliacal lymph nodes; A national case-study van den Berg, H.A.
 1997
 33 S8 p. S206-
1 p.
 artikel
1009 Postoperative radiotherapy in endometrial cancer: Analysis of 325 cases Őzkők, S.
 1997
 33 S8 p. S103-
1 p.
 artikel
1010 Postoperative radiotherapy in squamous cell carcinoma of the larynx — Prognostic factors Przeorek, W.
 1997
 33 S8 p. S190-
1 p.
 artikel
1011 Postoperative treatment of medulloblastoma in childhood 1986–1996 Kocsis, B.
 1997
 33 S8 p. S127-
1 p.
 artikel
1012 Post radiation severe xerostomia relieved by pilocarpine: A prospective French cooperative study Horlot, J.C.
 1997
 33 S8 p. S16-
1 p.
 artikel
1013 Potential doubling time (TPOT) in adenocarcinoma of the prostate Borre, M.
 1997
 33 S8 p. S33-
1 p.
 artikel
1014 p53 overexpression in node-negative breast cancer: Prognostic significance in a randomized study? Degeorges, A.
 1997
 33 S8 p. S194-S195
2 p.
 artikel
1015 P53, PCNA, Ki-67 in head and neck carcinoma Brunner, T.
 1997
 33 S8 p. S183-
1 p.
 artikel
1016 Precision of fractionated stereotactic conformation radiotherapy of brain tumours Kortmann, R.D.
 1997
 33 S8 p. S102-
1 p.
 artikel
1017 Preclinical and clinical experience with peptide-based vaccines against HPV16-induced tumors Melief, C.J.M.
 1997
 33 S8 p. S288-S289
2 p.
 artikel
1018 Predicting response in head and neck cancer: The search for the holy grall Coucke, Philippe A.
 1997
 33 S8 p. S289-S290
2 p.
 artikel
1019 Predictive and prognostic factors — Clinical relevance Scholl, S.
 1997
 33 S8 p. S134-
1 p.
 artikel
1020 Predictive genetics in cancer Murphy, A.E.
 1997
 33 S8 p. S297-
1 p.
 artikel
1021 Predictors of long-term survival in stage IV malignant melanoma (MM) patient Bafaloukos, D.
 1997
 33 S8 p. S258-
1 p.
 artikel
1022 Preliminary results from an early phase II combination of gemcitabine and taxol in metastatic breast cancer Sanchez-Rovira, P.
 1997
 33 S8 p. S154-
1 p.
 artikel
1023 Preliminary results of a randomised comparative phase III trial of topotecan versus CAV as second-line therapy of small cell lung cancer Clarke, P.
 1997
 33 S8 p. S228-
1 p.
 artikel
1024 Preliminary results of a randomised phase III trial of an established chemotherapy (CT) regimen with or without lenograstim (rHuG-CSF) in small cell lung cancer (SCLC): Impact on survival Gatzemeier, U.
 1997
 33 S8 p. S228-
1 p.
 artikel
1025 Preliminary results of a randomised study using WR-2721 in radiation therapy alone in patients with head and neck cancer Strnad, V.
 1997
 33 S8 p. S189-
1 p.
 artikel
1026 Preliminary study of GSH L-Cysteine Anthocyane (Recancostat CompositumTM) in metastatic colorectal carcinoma with relative denutrition Garcia-Giralt, E.
 1997
 33 S8 p. S171-
1 p.
 artikel
1027 Premedication one hour before the treatment with taxanes Samelis, G.F.
 1997
 33 S8 p. S21-
1 p.
 artikel
1028 Preoperative 5-fluorouracil and radiotherapy in rectal cancer Tejedor, M.
 1997
 33 S8 p. S172-
1 p.
 artikel
1029 Preoperative radio-chemo-therapy of soft tissue sarcomas—First results Fletkau, R.
 1997
 33 S8 p. S111-S112
2 p.
 artikel
1030 Preoperative radlochemotherapy in the treatment of Ewing's sarcoma Rübe, Ch.
 1997
 33 S8 p. S111-
1 p.
 artikel
1031 Preoperative thermoradiotherapy in combined treatment of rectal cancer patients Barsukov, U.A.
 1997
 33 S8 p. S171-
1 p.
 artikel
1032 Presence of germline BRCA2 mutations in sporadic breast cancer: Clinical correlation Gomendio, B.
 1997
 33 S8 p. S11-
1 p.
 artikel
1033 Pretreatment predictors of metastatic potential verified at autopsy in patients (pts) with inoperable non-small cell lung cancer (NSCLC) Stenbygaard, L.
 1997
 33 S8 p. S232-
1 p.
 artikel
1034 Pretreatment with retlnoic acid plus interferon improves tumor tissue oxygenation in cervical cancers Hänsgen, Gabriele
 1997
 33 S8 p. S208-
1 p.
 artikel
1035 Prevalence and severity of menopausal symptoms in women with a history of breast cancer Barker, S.
 1997
 33 S8 p. S82-
1 p.
 artikel
1036 Preventing affective disorder amongst partners of cancer patients Pitceathly, C.
 1997
 33 S8 p. S74-
1 p.
 artikel
1037 Prevention of anti-androgen induced gynecomastia in prostate cancer: Clinical experience in 85 patients treated with 12GY single dose electron irradiation Imgart, U.
 1997
 33 S8 p. S18-
1 p.
 artikel
1038 Prevention of extravasation during application of cytostatics via peripheral veins Bobnar, A.
 1997
 33 S8 p. S301-
1 p.
 artikel
1039 Primary advanced, recurrent and metastatic malignant melanoma clinical update on 20-year results of external beam radiotherapy Seegenschmiedt, M.H.
 1997
 33 S8 p. S255-
1 p.
 artikel
1040 Primary anorectal melanoma: Abdominoperineal resection or local resection? Dubé, P.
 1997
 33 S8 p. S256-
1 p.
 artikel
1041 Primary chemotherapy for early breast cancer: A revolution in progress Smith, I.E.
 1997
 33 S8 p. S134-
1 p.
 artikel
1042 Primary cytoreductive surgery in advanced ovarian carcinoma: Is it necessary in all patients? Vergote, I.B.
 1997
 33 S8 p. S139-
1 p.
 artikel
1043 Primary extranodal non Hodgkin's lymphoma of the head and neck (HN-NHL) Economopoulos, T.
 1997
 33 S8 p. S267-S268
2 p.
 artikel
1044 Primary gastric lymphoma — The Royal Marsden Hospital experience Popescu, R.A.
 1997
 33 S8 p. S265-
1 p.
 artikel
1045 Primary gastrointestinal lymphoma: Long-term follow-up of 75 patients treated in 2 german centers Sezer, O.
 1997
 33 S8 p. S268-
1 p.
 artikel
1046 Primary reconstruction after ablation of oral cancer — Effects on soft tissue function and life quality Schliephake, H.
 1997
 33 S8 p. S192-
1 p.
 artikel
1047 Primitive neuroectodermal tumours/extra-osseous Ewing's sarcoma. Ten years of experience at Portuguese institute of Oncology — Porto Dinis, José
 1997
 33 S8 p. S115-
1 p.
 artikel
1048 Problems in treatment and nursing of cancer patients Schoberberger, R.
 1997
 33 S8 p. S64-
1 p.
 artikel
1049 Problems related to high-dose-chemotherapie for cancer patient nursing Nieth, R.
 1997
 33 S8 p. S338-
1 p.
 artikel
1050 Professional nursing aspects of pulsed dose rate (PDR) brachytherapy Andersen, Christina
 1997
 33 S8 p. S329-S330
2 p.
 artikel
1051 Prognostic factors in low grade NHL (A multivariate analys) El Wahidi, G.F.
 1997
 33 S8 p. S269-
1 p.
 artikel
1052 Prognostic factors in non-curative gastric cancer Mudan, S.S.
 1997
 33 S8 p. S276-
1 p.
 artikel
1053 Prognostic factors in renal carcinoma Rűther, U.
 1997
 33 S8 p. S43-
1 p.
 artikel
1054 Prognostic factors in the management of clinical stage I (CS I) nonsemlnomatous germ ceil tumors of the testis (NSGCTT) Ondruš, D.
 1997
 33 S8 p. S43-
1 p.
 artikel
1055 Prognostic factors predictive of survival for retroperitoneal soft-tissue sarcoma in The Netherlands van Dalen, Th.
 1997
 33 S8 p. S110-
1 p.
 artikel
1056 Prognostic impact of minimal residual disease in patients with early breast cancer (T1) Diel, I.J.
 1997
 33 S8 p. S79-
1 p.
 artikel
1057 Prognostic impact of reoxygenation in cervical cancers treated with definitive radiotherapy Hänsgen, Gabriele
 1997
 33 S8 p. S98-
1 p.
 artikel
1058 Prognostic meaning of DNA ploidy in malignant melanoma and pigmented nevi Skowronek, Janusz
 1997
 33 S8 p. S259-
1 p.
 artikel
1059 Prognostic Relevance of Microvessel Density (MVD) in primary human breast cancer and lymph node metastase Grothey, A.
 1997
 33 S8 p. S194-
1 p.
 artikel
1060 Prognostic risk factors in low stage testicular nonseminomatous germ cell tumors (NSGCT) Heidenreich, A.
 1997
 33 S8 p. S38-S39
2 p.
 artikel
1061 Prognostic significance of axillary lymph node histology (pN) after neoadjuvant therapy for locally advanced breast cancer (LABC) Vitoc, C.
 1997
 33 S8 p. S151-
1 p.
 artikel
1062 Prognostic significance of irradiation of the posterior cervical lymph nodes in radiotherapy of oral cancer Niewald, M.
 1997
 33 S8 p. S186-
1 p.
 artikel
1063 Prognostic significance of monoclonal antibody MIB-1 in early stage larynx carcinoma Betten, Th.
 1997
 33 S8 p. S187-
1 p.
 artikel
1064 Prognostic significance of telomerase activity in breast cancer Hoos, A.
 1997
 33 S8 p. S198-
1 p.
 artikel
1065 Prognostic significance of the biologic feature of breast tumor Güler, N.
 1997
 33 S8 p. S198-
1 p.
 artikel
1066 Prolonged survival with complete resection of lung metastases İnanç, S.E.
 1997
 33 S8 p. S117-
1 p.
 artikel
1067 Prophylactic and therapeutic management of acute radiation related morbidity — Results of a German multicenter questionnaire Zimmermann, J.S.
 1997
 33 S8 p. S21-
1 p.
 artikel
1068 Prophylactic thyroidectomy in MEN IIA gene carriers — An intervention with a justifiable morbidity? Hotz, H.G.
 1997
 33 S8 p. S273-
1 p.
 artikel
1069 Prophylaxis by radiotherapy for heterotopic bone after acetabular fracture surgery Galalae, R.
 1997
 33 S8 p. S104-
1 p.
 artikel
1070 Proposal for an international multi center study: E-cadherin mutationspecific antibody to detect exon deletion in diffuse type gastric cancer Schuhmacher, C.
 1997
 33 S8 p. S279-
1 p.
 artikel
1071 Prospective analysis of factors affecting CD34+ cells mobilization in breast cancer patients Maroto, P.
 1997
 33 S8 p. S94-
1 p.
 artikel
1072 Prospective randomized study of mitoxantrone (M) and vinorelbine (V) vs fluorouracil (F), epirubicin (E) or adriamycin (A) and cyclophosphamide (C) in patients with advanced breast cancer (ABC) Turpin, F.
 1997
 33 S8 p. S146-
1 p.
 artikel
1073 Prostate cancer below 60 years of age: Increasing incidence and worsening prognosis? Post, P.N.
 1997
 33 S8 p. S31-
1 p.
 artikel
1074 Prostate cancer: Need for local control Schöder, Fritz H.
 1997
 33 S8 p. S294-
1 p.
 artikel
1075 Protection of salivary glands by amifostine in patients treated with high dose radioiodine Bohuslavizki, K.H.
 1997
 33 S8 p. S17-
1 p.
 artikel
1076 Protective action of EHF electromagnetic irradiation on cisplatin-suppressed functional activity of immune system cells Chekhun, V.
 1997
 33 S8 p. S20-S21
2 p.
 artikel
1077 Protocolized administration of naso-gastric tube feeding in children with cancer: Effects on nutritional status Den Broeder, E.
 1997
 33 S8 p. S56-
1 p.
 artikel
1078 PR-350, the least toxic 2-nitrolmldazole hypoxic cell radiosensitizer for clinical use Shibamoto, Y.
 1997
 33 S8 p. S25-S26
2 p.
 artikel
1079 Pseudocontinent perineal colostomy following abdominoperineal resection: Technique and findings in 40 patients Dubé, P.
 1997
 33 S8 p. S168-S169
2 p.
 artikel
1080 Pseudo opioid resistant cancer pain due to inadequate self- and family care Evers, G.
 1997
 33 S8 p. S303-
1 p.
 artikel
1081 p53 Status as potential predictor for response to chemotherapy in locally advanced gastric cancer Cascinu, S.
 1997
 33 S8 p. S276-
1 p.
 artikel
1082 Psychologic strain of patients in a follow-up program after curative resection of colorectal carcinoma Graupe, F.
 1997
 33 S8 p. S63-
1 p.
 artikel
1083 Public perception of cancer risk — An evaluation of calls to kid, the german cancer information service Hiller, Birgit
 1997
 33 S8 p. S59-S60
2 p.
 artikel
1084 Pylorus preserving partial duodenopancreatectomy for ductal pancreatic carcinoma Schoenberg, M.H.
 1997
 33 S8 p. S276-S277
2 p.
 artikel
1085 Quality assurance in breast cancer screening Del Turco, Marco Rosselli
 1997
 33 S8 p. S73-
1 p.
 artikel
1086 Quality control aspects in surgery Christiaens, M.R.
 1997
 33 S8 p. S135-
1 p.
 artikel
1087 Quality control program of radiation therapy in EORTC H8 protocol: The French centers experience Hennequin, C.
 1997
 33 S8 p. S261-S262
2 p.
 artikel
1088 Quality of life advantages demonstrated for patients receiving Tomudex compared with those receiving 5-f1uorouracll plus leucovorin (5 FU+LV) in the treatment of advanced colorectal cancer (ACC) Anderson, H.
 1997
 33 S8 p. S243-
1 p.
 artikel
1089 Quality of life after radical prostatectomy Biermann, C.W.
 1997
 33 S8 p. S57-
1 p.
 artikel
1090 Quality of life and personal feelings following quadrantectomy (Q) or mastectomy with reconstructive surgery (M+R) in breast cancer patient (b.c.p.) Molino, A.
 1997
 33 S8 p. S82-
1 p.
 artikel
1091 Quality of life as an outcome measure in cancer care Kiebert, G.M.
 1997
 33 S8 p. S5-
1 p.
 artikel
1092 Quality of life as outcome criteria of psychosocial rehabilitation program Weis, J.
 1997
 33 S8 p. S63-
1 p.
 artikel
1093 Quality of life in patients with advanced NSCLC: Evaluation of a neoadjuvant combined modality treatment Schumacher, A.
 1997
 33 S8 p. S62-S63
2 p.
 artikel
1094 Quality of life in sarcomas treated with limb salvage surgery or amputation Johansen, R.
 1997
 33 S8 p. S111-
1 p.
 artikel
1095 Quality of life (QL) is a prognostic factor (PF) for survival in patients with advanced colorectal cancer (CRC) Hilgenfeld, R.U.
 1997
 33 S8 p. S170-
1 p.
 artikel
1096 Quality of life (QoL) questionnaires: Everybody talks about them — But how to handle them? Boesgaard, M.
 1997
 33 S8 p. S304-
1 p.
 artikel
1097 Quantitative assessment of early and late postradiation skin reactions in breast cancer patients Warszawski, A.
 1997
 33 S8 p. S102-
1 p.
 artikel
1098 Radiation enhancement of Gemcitabine® In three human cervical cancer cell lines Wallwiener, D.
 1997
 33 S8 p. S204-
1 p.
 artikel
1099 Radiation induced anomalies in control of signal transduction in Ataxia telangiectasia and Fanconi anemia Moustacchi, E.
 1997
 33 S8 p. S70-
1 p.
 artikel
1100 Radiation-induces apoptosis in different pH environments in vitro Rödel, C.
 1997
 33 S8 p. S22-
1 p.
 artikel
1101 Radiation oncology in pancreatic cancer G.Willett, Christopher
 1997
 33 S8 p. S137-
1 p.
 artikel
1102 Radiation related toxicity in patients with limited stage small cell lung cancer (SCLC) receiving irradiation on primary tumor site after intensive chemotherapy Mikhina, Z.P.
 1997
 33 S8 p. S237-
1 p.
 artikel
1103 Radiation therapy choroidal neovascularization in age-related macular degeneration Engin, K.
 1997
 33 S8 p. S26-
1 p.
 artikel
1104 Radiation therapy for chemodectoma of the head and neck region; long term results Kawecki, A.
 1997
 33 S8 p. S107-
1 p.
 artikel
1105 Radiation therapy for primary vaginal cancers Hänsgen, G.
 1997
 33 S8 p. S205-
1 p.
 artikel
1106 Radiation therapy of intracranial pure germinoma: Result of the German prospective trial MAKEI '83, '86, '89 Kortmann, R.D.
 1997
 33 S8 p. S199-
1 p.
 artikel
1107 Radiation therapy of spinal metastases in breast cancer: A retrospective analysis of 108 patients Prié, L.
 1997
 33 S8 p. S151-
1 p.
 artikel
1108 Radiation (XRT) with electron beam rotation technique of chest wall in locally advanced breast cancer Hehr, T.
 1997
 33 S8 p. S150-
1 p.
 artikel
1109 Radical chemoradlation in stage III–IV cervix cancer: Pilot study Lozano, M.A.
 1997
 33 S8 p. S213-
1 p.
 artikel
1110 Radical gastrectomy — How do I do it? Stuart, R.C.
 1997
 33 S8 p. S5-
1 p.
 artikel
1111 Radical surgery and preservation of sphincter function in rectal cancer Schiessel, R.
 1997
 33 S8 p. S294-
1 p.
 artikel
1112 Radioactive colloid 198Au in combined modality treatment of lung cancer Yaskevich, L.S.
 1997
 33 S8 p. S241-
1 p.
 artikel
1113 Radiomodification in radiotherapy (AT) of patients with endometrial cancer (EC) Musukaev, B.
 1997
 33 S8 p. S106-
1 p.
 artikel
1114 Radiomodifiers in radiotherapy of uterine cancer Ivankova, V.
 1997
 33 S8 p. S213-
1 p.
 artikel
1115 Radioperoxidation of human low-density lipoproteins (LDL): Antioxidant activity of a vitamin E derivative (MOH) -effect of the dose rate Clavere, P.
 1997
 33 S8 p. S28-
1 p.
 artikel
1116 Radiosensitizing effects of cisplatin and carboplatin in prostate cancer cell lines Geldof, A.A.
 1997
 33 S8 p. S26-
1 p.
 artikel
1117 Radiosurgery alternatives and outcomes Gaspar, L.
 1997
 33 S8 p. S201-
1 p.
 artikel
1118 Radiotherapy alone in curative sphincter preserving management of rectal cancers Maingon, P.
 1997
 33 S8 p. S162-
1 p.
 artikel
1119 Radiotherapy and 5-FU after curative resection for the cancer of the pancreas and peri-ampullary region: A phase III trial of the EORTC GITCCG Klinkenbijl, J.H.G.
 1997
 33 S8 p. S274-
1 p.
 artikel
1120 Radiotherapy and hyperthermia in inoperable pelvic tumours: Results of Dutch randomized studies van der Zee, J.
 1997
 33 S8 p. S205-S206
2 p.
 artikel
1121 Radiotherapy for choroidal metastases in breast cancer — Results of a prospective study of the ARO (ARO 95-08) Wiegel, T.
 1997
 33 S8 p. S151-
1 p.
 artikel
1122 Radiotherapy for oesophagus carcinoma: The impact of p53 on treatment outcome Pomp, J.
 1997
 33 S8 p. S100-
1 p.
 artikel
1123 Radiotherapy in cancer of corpus uteri — Indications, technique and results Bey, P.
 1997
 33 S8 p. S78-
1 p.
 artikel
1124 Radiotherapy-induced changes of psychological health in patients after breast conserving surgery Rahn, A.N.
 1997
 33 S8 p. S62-
1 p.
 artikel
1125 Radiotherapy in stage I and II seminoma Jelić, Lj.R.
 1997
 33 S8 p. S42-
1 p.
 artikel
1126 Radiotherapy in treatment of Ewing's sarcoma of the chest wall (Askin tumors) Schuck, A.
 1997
 33 S8 p. S125-
1 p.
 artikel
1127 Radiotherapy of early localised rectal cancer Gerárd, J.P.
 1997
 33 S8 p. S218-
1 p.
 artikel
1128 Radiotherapy with carbogen breathing and nicotinamide in locally advanced non-small cell lung cancer (NSCLC) Yavuz, A.A.
 1997
 33 S8 p. S101-S102
2 p.
 artikel
1129 Radlochemotherapy for carcinoma of the anal canal Schneider, I.
 1997
 33 S8 p. S243-
1 p.
 artikel
1130 Randomised clinical study (phase III) FE vs. FEP in advanced gastric cancer Roth, A.
 1997
 33 S8 p. S275-
1 p.
 artikel
1131 Randomized clinical trial of continuous accelerated irradiation (CAIR - 7 days a week) for head and neck cancer. Preliminary treatment results Skladowski, K.
 1997
 33 S8 p. S186-
1 p.
 artikel
1132 Randomized multicentric study of perioperative chemotherapy with mitoxantrone (MTZ) in early breast cancer Petit, T.
 1997
 33 S8 p. S80-
1 p.
 artikel
1133 Randomized phase III trial of active specific immunotherapy (ASI) versus control in patients with Duke's B2, B3 or C colon cancer Vermorken, J.B.
 1997
 33 S8 p. S162-
1 p.
 artikel
1134 Randomized trial comparing preoperative irradiation versus the use of non-steroidal-antiinflammatory drugs for prevention of heterotopic ossification following prothetic total hip replacement Kölbl, O.
 1997
 33 S8 p. S98-
1 p.
 artikel
1135 Randomized trial of cisplatin (P) plus 5-fluorouracil (F) with or without folinic acid in locally advanced head and neck cancer (LAHNC) Cruz, J.J.
 1997
 33 S8 p. S190-
1 p.
 artikel
1136 Randomized trial of platin (MVP) vs. non-platin-chemotherapy (MACC) in non-small cell lung cancer (NSCLC): A negative report from the cuneo lung cancer study group Buccheri, G.
 1997
 33 S8 p. S235-
1 p.
 artikel
1137 Randomized trials evaluating radiotherapy adjuvant to chemotherapy for small cell lung carcinoma (SCLC): Qualitative evaluation before meta-analysis Berghmans, T.
 1997
 33 S8 p. S228-
1 p.
 artikel
1138 Randomlsed controlled trial of supportive care in radical pelvic radiotherapy: Does it influence radiation morbidity? Faithfull, S.
 1997
 33 S8 p. S16-
1 p.
 artikel
1139 RBC flux of the portio uteri & cervical carcinoma — The in vivo use of colposcopy directed laser doppler fluxmetry (LDF) Haase, F.
 1997
 33 S8 p. S207-
1 p.
 artikel
1140 Recent developments in radiotherapy; do nurses really meet patients needs? Wells, M.
 1997
 33 S8 p. S337-
1 p.
 artikel
1141 Recent developments in radiotherapy: Do nurses really meet the patients needs? Vandevelde, Guy
 1997
 33 S8 p. S337-
1 p.
 artikel
1142 Recombinant human granulocyte colony-stimulating factor (G-SCF) in patients receiving chemotherapy for gynecologic cancer Cardamakis, E.
 1997
 33 S8 p. S19-
1 p.
 artikel
1143 Recurrence and prognosis after curative resection for early gastric cancer Horback, Th.
 1997
 33 S8 p. S281-
1 p.
 artikel
1144 Recurrent breast cancer: Thermo-radiotherapy once versus twice weekly hyperthermia — A prospective randomized study Klautke, G.
 1997
 33 S8 p. S148-
1 p.
 artikel
1145 Recurrent gastrointestinal sarcoma: Survival analyses and patterns of failure Mudan, S.S.
 1997
 33 S8 p. S110-
1 p.
 artikel
1146 Reflections about nursing during highly aggressive chemotherapy especially in peripheral blood stem cell transplantation Santjer, T.
 1997
 33 S8 p. S329-
1 p.
 artikel
1147 Regional therapy for melanoma: Randomlsed trials Lejeune, F.
 1997
 33 S8 p. S291-
1 p.
 artikel
1148 Rehabilitation of oncological patients' in Lithuania Matilionis, V.
 1997
 33 S8 p. S56-
1 p.
 artikel
1149 Re-186-HEDP for palliation of pain in patients with metastatic bone disease — Preliminary results Giannakenas, C.
 1997
 33 S8 p. S58-
1 p.
 artikel
1150 Relation between IL-10 and IL-12 secretion in Hodgkin's disease (HD) Viviani, S.
 1997
 33 S8 p. S271-
1 p.
 artikel
1151 Relationship between rate of “in-field” bone marrow regeneration and radiation dose in patients with Hodgkin's disease Kanayev, S.V.
 1997
 33 S8 p. S270-
1 p.
 artikel
1152 Relationship of p53, uPA, pS2, EGF-R, and c-ERBB2, with response to systemic treatment in recurrent breast cancer patient Klijn, J.G.M.
 1997
 33 S8 p. S196-
1 p.
 artikel
1153 RENCA — An animal model for the development of anti-angiogenic strategies Dreys, J.
 1997
 33 S8 p. S49-
1 p.
 artikel
1154 Repeat mediastinoscopy after neo-adjuvant chemotherapy in stage III (N2) non-small cell lung cancer (NSCLC)? Maesen, B.
 1997
 33 S8 p. S232-
1 p.
 artikel
1155 Rescue treatment with etoposide, platinum, ifosfamide and dexamethasone for non-Hodgkin's lymphoma Cervantes, G.
 1997
 33 S8 p. S266-
1 p.
 artikel
1156 Resection margins in melanoma surgery and the value of elective lymphnode dissection Drzewiecki, K.T.
 1997
 33 S8 p. S290-
1 p.
 artikel
1157 Response and cosmesls of two, short duration radiotherapy regimens for epidemic cutaneous Kaposi's sarcoma Harrison, Mark
 1997
 33 S8 p. S99-
1 p.
 artikel
1158 Response and early progression according to CA 125 to assess activity of topotecan vs paclitaxel in relapsed ovarian carcinoma Rustin, G.J.S
 1997
 33 S8 p. S118-
1 p.
 artikel
1159 Response of two different human squamous cell carcinoma xenografts to irradiation at varying sizes: Relationship between tumor volume and TCD50 Schreibe, A.
 1997
 33 S8 p. S24-
1 p.
 artikel
1160 Response to chemotherapy is the first prognostic factor in metastatic breast cancer Pierga, J.Y.
 1997
 33 S8 p. S147-
1 p.
 artikel
1161 Response to primary chemotherapy of breast cancer Junkermann, D.
 1997
 33 S8 p. S147-
1 p.
 artikel
1162 Restaging breast cancer after somatostatin receptor scintigraphy with [111In-DTPA-Phe-1]-Octreotide Giannakenas, C.
 1997
 33 S8 p. S51-
1 p.
 artikel
1163 Results and prognostic factors after surgical treatment of lung metastases in renal cell carcinoma Hofmann, H.-S.
 1997
 33 S8 p. S40-
1 p.
 artikel
1164 Results of combined HDR-brachytherapy and external beam therapy in patients with high risk endometrial carcinoma Tatzreiter, G.
 1997
 33 S8 p. S209-
1 p.
 artikel
1165 Results of conformal radiotherapy in prostate cancer Schwarz, R.
 1997
 33 S8 p. S31-
1 p.
 artikel
1166 Results of mantle irradiation alone in adult patients with clinical stage (CS) I and II Hodgkin's disease (HD) with low probability of abdominal involvement and good prognostic factors Regueiro, C.A.
 1997
 33 S8 p. S270-S271
2 p.
 artikel
1167 Results of radiation therapy and combined radio-ehemotherapy in the treatment of the CB-CC non-Hodgkin's lymphoma Schultze, J.
 1997
 33 S8 p. S267-
1 p.
 artikel
1168 Results of the combined external- and Ir192 HDR-afterloadlng radiotherapy of cervical and endometrial cancer using an individual middle-block technique Wilhelm, R.
 1997
 33 S8 p. S207-S208
2 p.
 artikel
1169 Re-treatment of locally recurrent or persistent nasopharyngeal carcinoma by second course radiotherapy Chang, J.T.
 1997
 33 S8 p. S99-
1 p.
 artikel
1170 Retroperitoneal sarcomas — Prognostic value of ploidy and other important factors Herman, K.
 1997
 33 S8 p. S112-
1 p.
 artikel
1171 Retrospective analysis of 30 intracranial ependymoma Koçak, Z.
 1997
 33 S8 p. S202-
1 p.
 artikel
1172 Reversal of multidrug resistance by externally added or gene transduced cytokines: An alternative approach Stein, U.
 1997
 33 S8 p. S174-
1 p.
 artikel
1173 Reverse Isolation in pediatric oncology: Sense or nonsense? Schönherr, U.
 1997
 33 S8 p. S340-
1 p.
 artikel
1174 Review of dietary advice given to patients undergoing total body irradiation (TBI) at a regional oncology centre in the United Kingdom Cuthbertson, E.
 1997
 33 S8 p. S323-
1 p.
 artikel
1175 Risk estimation for side effects of radiotherapy in patients with prostate cancer Weigel, Ch.
 1997
 33 S8 p. S35-
1 p.
 artikel
1176 Risk factors and reversibility of neurotoxicity induced by high-dose paclitaxel Mayordmo, J.I.
 1997
 33 S8 p. S20-
1 p.
 artikel
1177 Risk of second primary cancer in hereditary and non-hereditary retinoblastoma: Results from a population based study with more than 40 years fOllow-up Alsner, J.
 1997
 33 S8 p. S128-
1 p.
 artikel
1178 Role of chloroacetaldehyde for the cytotoxic efficacy of Ifosfamid: Examinations on human tumor and renal tubular cell lines Kisro, J.
 1997
 33 S8 p. S178-
1 p.
 artikel
1179 Role of high-dose chemotherapy and autologous bone marrow transplantation in the treatment of lymphoma Philip, T.
 1997
 33 S8 p. S221-
1 p.
 artikel
1180 Role of lymph node dissection In malignant melanoma — New aspects Meyer, Th.
 1997
 33 S8 p. S255-
1 p.
 artikel
1181 Role of 99mTc-Sestamibi for diagnosis, staging and follow up of patient with lung cancer Sergieva, S.
 1997
 33 S8 p. S238-
1 p.
 artikel
1182 Role of radical radiotherapy (RRT) in the treatment of inoperable invasive bladder cancer in the elderly Toscano, G.
 1997
 33 S8 p. S34-
1 p.
 artikel
1183 RT-PCR detection of melanoma cells in peripheral blood stem cell harvests of patients with metastatic malignant melanoma Schrader, A.
 1997
 33 S8 p. S260-
1 p.
 artikel
1184 Safety of adjuvant mAb 17-1A in colorectal cancer (CRC) Schmoll, H.J.
 1997
 33 S8 p. S168-
1 p.
 artikel
1185 Sarcomas of the nasal cavity and paranasal sinuses Dahle, J.
 1997
 33 S8 p. S185-
1 p.
 artikel
1186 Scalp hypothermia for 2 hours prevents alopecia after adriamycin based chemotherapy Fiebig, H.H.
 1997
 33 S8 p. S53-
1 p.
 artikel
1187 Schedule-clependent myelotoxlclty induced in vitro by the new marine derived minor groove interacting agent ecteinascldln 743 Ghlelmini, M.
 1997
 33 S8 p. S180-
1 p.
 artikel
1188 Screening programmes for prostate cancer. Is it worthwhile? Weyler, J.
 1997
 33 S8 p. S68-
1 p.
 artikel
1189 Searching for solutions to the problem of fatigue in cancer patients in the United Kingdom: The action on fatigue programme Richardson, A.
 1997
 33 S8 p. S300-
1 p.
 artikel
1190 Secondary tumors in longsurvival patients with Hodgkin (HDK) disease Provenclo, M.
 1997
 33 S8 p. S268-
1 p.
 artikel
1191 Second line chemotherapy (CT) in advanced non small cell lung cancer (NSCLC) Westeel, V.
 1997
 33 S8 p. S235-
1 p.
 artikel
1192 Second line treatment of non-small cell lung cancer with paclitaxel and gemcitabine Kakolyris, S.
 1997
 33 S8 p. S232-
1 p.
 artikel
1193 Secretion of immunomodulating GM-CSF and M-CSF by human renal cell carcinoma of different types Reinecke, P.
 1997
 33 S8 p. S39-
1 p.
 artikel
1194 Selective cytoprotection by amifostine (A) in the treatment of head and neck cancer with simultaneous radiochemotherapy (RCT) Büntzel, J.
 1997
 33 S8 p. S189-
1 p.
 artikel
1195 Sequential adrlamycin (A), docetaxel (D) and CMF in the adjuvant treatment (AT) of breast cancer (BC) Di Leo, A.
 1997
 33 S8 p. S83-
1 p.
 artikel
1196 Serum CEA indicates presence of lymph node metastases and response to preoperative radio-chemo-thermotherapy in locally advanced rectal cancer Rau, B.
 1997
 33 S8 p. S163-
1 p.
 artikel
1197 Serum concentrations of soluble interleucin-2 receptors (sIL-2R) in patients with benign and malignant ovarian tumors Gebauer, G.
 1997
 33 S8 p. S122-
1 p.
 artikel
1198 Serum immunoreactive thrombopoietin levels in patients and response to ICE-chemotherapy-induced thrombocytopenia Heits, F.
 1997
 33 S8 p. S19-
1 p.
 artikel
1199 Serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients (pts) with soft tissue sarcoma (STS) Graeven, U.
 1997
 33 S8 p. S112-
1 p.
 artikel
1200 Serum L-Selectin and P-Selectin levels in lymphomas Haznedaroğlu, I.C.
 1997
 33 S8 p. S268-
1 p.
 artikel
1201 Serum tumor markers in gastrointestinal cancer patients: A prospective longitudinal study Guadagni, F.
 1997
 33 S8 p. S275-
1 p.
 artikel
1202 Short term vs lifelong adjuvant tamoxifen in early breast cancer (EBC): A randomized trial (TAM-01) Delozier, T.
 1997
 33 S8 p. S80-
1 p.
 artikel
1203 Should audio-recordings be used in nurse/patient communication? McDonald, R.
 1997
 33 S8 p. S312-
1 p.
 artikel
1204 Signal transducers as molecular targets for cancer therapy Bardelli, A.
 1997
 33 S8 p. S143-
1 p.
 artikel
1205 Significance of matrix metalloproteinase 9 (MMP-9) and matrix metalloprotelnase 3 (MMP-3) expression during liver metastasis in colorectal cancer Inuzuka, K.
 1997
 33 S8 p. S166-
1 p.
 artikel
1206 Significantly improved survival with 'arimldex' (anastrozole (A)) compared with megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC): Updated results of two randomised trials Jonat, W.
 1997
 33 S8 p. S145-
1 p.
 artikel
1207 Single agent carboplatin or radiotherapy as adjuvant in stage I seminoma — Results of a prospective trial Wiegel, T.
 1997
 33 S8 p. S39-
1 p.
 artikel
1208 Six years experience using inhalatory interleukin-2 in pulmonary metastatic renal cell carcinoma Huland, E.
 1997
 33 S8 p. S86-
1 p.
 artikel
1209 Skin changes in successfully treated Hodgkin's disease patient Stockfleth, E.
 1997
 33 S8 p. S263-
1 p.
 artikel
1210 Smoking cessation in patients with head and neck cancer Grönroos, P.
 1997
 33 S8 p. S191-
1 p.
 artikel
1211 Soft agar cloning evaluation of effects of amifostine on clonogenic growth of freshly explanted human tumors in short term exposure in vitro Pohl, P.
 1997
 33 S8 p. S178-
1 p.
 artikel
1212 Soft tissue sarcomas: Results of a retrospective study Julieta Silva, M.
 1997
 33 S8 p. S115-
1 p.
 artikel
1213 Soft tissue sarcomas — Surgical tactics and multimodality treatment Klein, P.
 1997
 33 S8 p. S117-
1 p.
 artikel
1214 Soft tissues granular cell tumor: Disease description and treatment Dubé, P.
 1997
 33 S8 p. S114-
1 p.
 artikel
1215 Soluble tumor markers in malignant melanoma. A quantitative analysis of S-100, of CD44 and of its variant isoform Grossi, F.
 1997
 33 S8 p. S258-
1 p.
 artikel
1216 Soluble VCAM-1 as predictor of survival in patients with advanced malignant melanoma Atzpodien, J.
 1997
 33 S8 p. S257-
1 p.
 artikel
1217 Somatostatin receptor scintigraphy for the initial staging of Hodgkin's disease van den Anker-Lugtenburg, P.J.
 1997
 33 S8 p. S262-
1 p.
 artikel
1218 Somatostatin receptor scintigraphy for the initial staging of non-Hodgkin's lymphomas Van den anker-Lugtenburg, P.J.
 1997
 33 S8 p. S265-
1 p.
 artikel
1219 Somatostatin receptor scintigraphy (SSRS) in GEP-tumors Krenning, E.P.
 1997
 33 S8 p. S272-
1 p.
 artikel
1220 Specialist hospital based palliative care service in Ireland Hogan, Moma
 1997
 33 S8 p. S309-
1 p.
 artikel
1221 Specific DNA sequences — A new target? Hartley, John A.
 1997
 33 S8 p. S224-
1 p.
 artikel
1222 Specificities and optimization or peripheral blood stem cell collection in children: Treatment for malignancies can be mobilization Brault, Ph.
 1997
 33 S8 p. S126-
1 p.
 artikel
1223 Sphincter preserving surgery for rectal cancer Roelofsen, F.
 1997
 33 S8 p. S142-
1 p.
 artikel
1224 Sphincter-saving operations for cancer localised in the distal half of the rectum Dimitrov, V.
 1997
 33 S8 p. S166-
1 p.
 artikel
1225 Splenectomy in patients with non-Hodgkin's lymphoma Xiros, N.
 1997
 33 S8 p. S267-
1 p.
 artikel
1226 Staging and treatment of early rectal cancer Schlag, P.M.
 1997
 33 S8 p. S217-S218
2 p.
 artikel
1227 Staging laparoscopy for gastro-intestinal tract malignancies Honhenberger, Peter
 1997
 33 S8 p. S142-
1 p.
 artikel
1228 Standard & non-standard applications of sentinel node (SN) guided melanoma (MM) surgery Gutman, H.
 1997
 33 S8 p. S256-
1 p.
 artikel
1229 Standards of reference in early breast cancer post-operative irradiation: The Italian association for radiation oncology (AIRO) document Valdagni, R.
 1997
 33 S8 p. S104-
1 p.
 artikel
1230 Static disease (sd) of long duration (≥24 weeks) is an important remission criterion in breast cancer patients treated with the aromatase inhibitor anastrozole (AN) Robertson, J.F.R.
 1997
 33 S8 p. S150-
1 p.
 artikel
1231 Stealth liposome entrapped doxorubicin (SLED) and clsplatin (SLEC) versus head and neck xenograft tumours Harrington, K.J.
 1997
 33 S8 p. S179-
1 p.
 artikel
1232 Stereotactic external beam radiotherapy of brain metastases — Clinical results of a prospective study Grosu, A.L.
 1997
 33 S8 p. S204-
1 p.
 artikel
1233 Stereotactic radiotherapy for brain tumours-fact & fiction Brada, M.
 1997
 33 S8 p. S144-
1 p.
 artikel
1234 Steroid hormone receptors in lung cancer: Differential expression, function and clinical significance Kaiser, U.
 1997
 33 S8 p. S238-
1 p.
 artikel
1235 Stimulation of cytotoxicity and cytoklne production in tumor — Associated macrophages from ovarian, breast and lung cancer patients Zavadova, E.
 1997
 33 S8 p. S123-
1 p.
 artikel
1236 Strong correlation of basement membrane degradation with up-regulation of metalloprotelnases by functional p53 loss Özdemir, E.
 1997
 33 S8 p. S34-
1 p.
 artikel
1237 Structured patient information in radiotherapy departments in Europe Kantor, G.
 1997
 33 S8 p. S223-
1 p.
 artikel
1238 Study of two intravenous schedules of clodronate (CL) in patients with bone metastases Semiglazov, V.V.
 1997
 33 S8 p. S55-
1 p.
 artikel
1239 Subcutaneous (SC) interleukin-2 (IL-2) plus alpha interferon (IFN-α) and 5 fluorouracil (5 FU) in out-patients (pts) with metastatic renal cell carcinoma (MRCC). Scapp II trial Tourani, J.M.
 1997
 33 S8 p. S36-
1 p.
 artikel
1240 Subject index 1997
 33 S8 p. S375-S380
6 p.
 artikel
1241 Successful treatment with paclitaxel/5-FU and simultaneous radiation in advanced H&N carcinoma Schroeder, M.
 1997
 33 S8 p. S192-S193
2 p.
 artikel
1242 Supporting the dying cancer patient's family in hospital: Using research to improve practice Mcintyre, Rosemary
 1997
 33 S8 p. S320-
1 p.
 artikel
1243 Surgery for metastatic disease Papa, M.Z.
 1997
 33 S8 p. S77-
1 p.
 artikel
1244 Surgery: Still the gold standard? Lerut, T.
 1997
 33 S8 p. S291-S292
2 p.
 artikel
1245 Surgical management of primary and recurrent soft tissue sarcomas of the retroperitoneum Bonvalot, S.
 1997
 33 S8 p. S110-
1 p.
 artikel
1246 Surgical therapy of gastric carcinoma in the elderly Piso, P.
 1997
 33 S8 p. S278-S279
2 p.
 artikel
1247 Surgical therapy of the squamous cell carcinoma of the thoracal esophagus Göhl, J.
 1997
 33 S8 p. S278-
1 p.
 artikel
1248 Surgical treatment of brain tumors Comu, Ph.
 1997
 33 S8 p. S293-
1 p.
 artikel
1249 Surgical treatment of lymph node metastases of papillary thyroid carcinoma—Possible prognostic value Džodić, R.
 1997
 33 S8 p. S274-
1 p.
 artikel
1250 Surgical treatment of pancreatic cancer — Recent progress Beger, H.G.
 1997
 33 S8 p. S136-S137
2 p.
 artikel
1251 Surgical treatment of regional neck nodes in the head and neck squamous carcinoma Jones, A.S.
 1997
 33 S8 p. S290-
1 p.
 artikel
1252 Survival following treatment with RMP-7 and carboplatin in malignant glioma who grade III–IV: Comparison with matched controls Osborn, C.
 1997
 33 S8 p. S200-
1 p.
 artikel
1253 Survival in breast cancer associated with germline mutations of BRCA1 Verhoog, L.C.
 1997
 33 S8 p. S7-
1 p.
 artikel
1254 Survival in renal cell carcinoma (RCC)— A randomised evaluation of tamoxifen versus interleukin-2, α-interferon (leukocyte) and tamoxifen Henriksson, R.
 1997
 33 S8 p. S37-
1 p.
 artikel
1255 Symptom assessment — A prerequisitite achieving optimum nursing care Uitterhoeve, R.J.
 1997
 33 S8 p. S307-
1 p.
 artikel
1256 Symptom control and clinical benefit in advanced non-small cell lung cancer: Early report of a randomized study of gemclcitabine monotherapy versus cisplatinum-vindesine Vansteenkiste, J.
 1997
 33 S8 p. S237-
1 p.
 artikel
1257 Symptom distress in patients with advanced non-small cell lung cancer treated with chemotherapy Radosavliević, D.
 1997
 33 S8 p. S238-
1 p.
 artikel
1258 Symptom occurrence and symptom distress in chemotherapy patients evaluated by patients and nurses Tanghe, A.
 1997
 33 S8 p. S298-S299
2 p.
 artikel
1259 Systemic treatment of metastatic malignant melanoma Benhammouda, A.
 1997
 33 S8 p. S291-
1 p.
 artikel
1260 Tamoxifen and vaginal and cervical cytology and sonographical changes of endometrium Friedrich, M.
 1997
 33 S8 p. S211-
1 p.
 artikel
1261 Targeted cytokine delivery with recombinant antibody fusion proteins for therapeutic intervention Lode, Holger N.
 1997
 33 S8 p. S70-
1 p.
 artikel
1262 Targeted delivery of esperamicine A1 by using oncofetal protein α-fetoprotein Severin, S.E.
 1997
 33 S8 p. S89-
1 p.
 artikel
1263 Targeted immunotherapy: Dendritic cells to present tumor-associated antigens Figdor, Carl G.
 1997
 33 S8 p. S291-
1 p.
 artikel
1264 Taxol-like premedication reduces the toxicity of amifostine Bijvank, Elise
 1997
 33 S8 p. S328-S329
2 p.
 artikel
1265 Taxol™ (Paclitaxel), Epirubicin and Cyclophosphamide (TEC) in the treatment of metastatic breast cancer (MBC): Results of a phase I study Nabholtz, J.-M.
 1997
 33 S8 p. S153-
1 p.
 artikel
1266 TAXOL® (paclitaxel) 1-hour infusion plus doxorubicin as first line treatment for metastatic breast cancer (MBC) patients Mickiewicz, E.
 1997
 33 S8 p. S152-
1 p.
 artikel
1267 Taxol (T) and mitoxantrone (M) as first line treatment in advanced breast cancer (ABC) patients. A phase II study of the Southern Italy oncology group (GOIM) Giotta, F.
 1997
 33 S8 p. S155-
1 p.
 artikel
1268 Taxol (T) versus doxorubicin (D) as first-line chemotherapy (CT) in advanced breast cancer (ABC): An EORTC randomized study with crossover Paridaens, R.
 1997
 33 S8 p. S145-
1 p.
 artikel
1269 Taxotere and clsplatln In metastatic urothelial cancer: A phase II study Sengeløv, L.
 1997
 33 S8 p. S30-
1 p.
 artikel
1270 Taxotere-cisplatin (TC) in advanced gastric carcinoma (AGC): A promising drug combination Roth, A.D.
 1997
 33 S8 p. S275-S276
2 p.
 artikel
1271 Taxotere™ (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in the treatment of metastatic breast cancer (MBC) Nabholtz, J.-M.
 1997
 33 S8 p. S146-
1 p.
 artikel
1272 Taxotere in the treatment of patients with advanced breast cancer Bonsova, T.
 1997
 33 S8 p. S154-
1 p.
 artikel
1273 T cell recognition of melanoma-derived antigens: Implication for peptide based immunotherapy Rivoltini, L.
 1997
 33 S8 p. S291-
1 p.
 artikel
1274 T cell retargeting for local and systemic control of disease Canevan, S.
 1997
 33 S8 p. S139-
1 p.
 artikel
1275 Tc-99m MISI uptake in advanced breast cancer: Predictive value of response to chemotherapy Delgado, L.
 1997
 33 S8 p. S199-
1 p.
 artikel
1276 Telephone triage with a questionnaire, used by the department of palliative care unit (PCU) on-call out of hours Elfrink, E.J.
 1997
 33 S8 p. S303-
1 p.
 artikel
1277 Telomerase activity and telomere length in testicular cancer tissues and residual tumor mass after cisplatin based chemotherapy Burger, A.M.
 1997
 33 S8 p. S38-
1 p.
 artikel
1278 Telomerase activity in benign and malignant human thyroid disorders Cheng, A.-J.
 1997
 33 S8 p. S272-S273
2 p.
 artikel
1279 Teniposide, mitomicin C and cisplatin combination in treatment of advanced gastric cancer Bazin, I.
 1997
 33 S8 p. S279-S280
2 p.
 artikel
1280 Testicular cancer: Human placental alkaline phosphatase (hPLAP) Pottek, T.S.
 1997
 33 S8 p. S43-
1 p.
 artikel
1281 Testicular cancer — Staging, treatment and outcome Mead, G.M
 1997
 33 S8 p. S6-
1 p.
 artikel
1282 Testis cancer: Carcinoma-in-situ in testes with germ cell tumour Poltek, T.S.
 1997
 33 S8 p. S37-
1 p.
 artikel
1283 Testis cancer: Endocrinological disturbancies Pottek, T.S.
 1997
 33 S8 p. S42-S43
2 p.
 artikel
1284 TGF-ß1 resistance as a major progression factor in human renal cell carcinoma Ramp, U.
 1997
 33 S8 p. S40-
1 p.
 artikel
1285 The acceptance of psychosocial intervention by a group of breast cancer patients Ditz, S.
 1997
 33 S8 p. S63-
1 p.
 artikel
1286 The alleviation of suffering in the care of cancer patients with incurable illness Kuuppelomäki, M.
 1997
 33 S8 p. S304-
1 p.
 artikel
1287 The AMC nursing approach for patients who need an oesophageal resection Weststrate, M.
 1997
 33 S8 p. S298-
1 p.
 artikel
1288 The antihypercalcemic action of gallium-nitrate is not due to inhibition of parathormone or parathormone-related protein secretion in rats Schilling, T.
 1997
 33 S8 p. S179-
1 p.
 artikel
1289 The application of ethical principles to the implementation of nursing research findings Browne, S.E.
 1997
 33 S8 p. S332-
1 p.
 artikel
1290 The arteriography technique of the thyroid cancer complex diagnosis Tâbârna, Gh.
 1997
 33 S8 p. S192-
1 p.
 artikel
1291 The biology of Hodgkin's disease Jox, A.
 1997
 33 S8 p. S220-
1 p.
 artikel
1292 The challenge of informed consent Meran, J.G.
 1997
 33 S8 p. S74-S75
2 p.
 artikel
1293 The changing landscape of breast cancer clinical research Piccart, Martine J.
 1997
 33 S8 p. S284-
1 p.
 artikel
1294 The Classification of the non-Hodgkin's lymphomas. Results from the International Lymphoma Classification Project MacLennan, K.A.
 1997
 33 S8 p. S220-S221
2 p.
 artikel
1295 The Clinical Research Unit — A nurse-led unit for cancer patients receiving chemotherapy in phase I clinical trials Cameron, C.
 1997
 33 S8 p. S334-
1 p.
 artikel
1296 The comparison of somatostatin receptor and 67-gallium scintigraphy in the staging of malignant lymphomas Van den anker-Lugtenburg, P.J.
 1997
 33 S8 p. S266-
1 p.
 artikel
1297 Theconsensus process in Europe Williams, C.J.
 1997
 33 S8 p. S293-
1 p.
 artikel
1298 The development of a manual on research nursing: The ECSG research nurses group van Wijk, Atle W.
 1997
 33 S8 p. S299-S300
2 p.
 artikel
1299 The E1a gene as antitumor agent: Trials in murine experimental models Sánchez, R.
 1997
 33 S8 p. S86-S87
2 p.
 artikel
1300 The early diagnosis of cutaneous malignant melanoma: The role of the epiluminesent microscopy Ascierto, P.A.
 1997
 33 S8 p. S255-
1 p.
 artikel
1301 The effect of adjuvant tamoxifen therapy in postmenopausal women on thyroid function tests Zidan, J.
 1997
 33 S8 p. S21-
1 p.
 artikel
1302 The effect of oral clodronate on bone minerai density in women with primary breast cancer Powles, T.J.
 1997
 33 S8 p. S80-
1 p.
 artikel
1303 The effect of the interval between surgery and radiotherapy on local control and overall survival in patients with breast cancer Özseker, N.
 1997
 33 S8 p. S84-
1 p.
 artikel
1304 The effects of different treatment models on Turkish women with uterine sarcoma Berrak, E.
 1997
 33 S8 p. S209-
1 p.
 artikel
1305 The efficacy of gemcitabine in controlling pain and improving performance status in men with hormone-refractory prostate cancer (HRPC) Ahmann, F.R.
 1997
 33 S8 p. S36-
1 p.
 artikel
1306 The efficacy of interferon alpha in polycythemia vera Öztürk, A.
 1997
 33 S8 p. S89-S90
2 p.
 artikel
1307 The efficacy of radiosurgery (RS) alone or in combination with whole brain irradiation for brain metastases Piizkall, A.
 1997
 33 S8 p. S200-
1 p.
 artikel
1308 The efficacy of the NMDA receptor antagonist amantadine in the treatment of neuropathic cancer pain: A double blind, randomized, placebo-controlled trial Pud, D.
 1997
 33 S8 p. S53-
1 p.
 artikel
1309 The efficiency of total liver irradiation (TLI) in patients with Hodgkin'S disease (HD) Balashov, A.T.
 1997
 33 S8 p. S108-
1 p.
 artikel
1310 The ERB-B family of receptor tyrosine kinases: Their role in cancer development and as targets for therapy Hynes, N.E.
 1997
 33 S8 p. S144-
1 p.
 artikel
1311 The European network of cancer registries: Improving basic information on cancer frequency and outcome in Europe Black, R.J.
 1997
 33 S8 p. S73-
1 p.
 artikel
1312 The European prospective investigation into cancer, nutrition and health (EPIC) González, C.A.
 1997
 33 S8 p. S73-
1 p.
 artikel
1313 The European quality assurance program in radiotherapy Leer, J.W.
 1997
 33 S8 p. S137-
1 p.
 artikel
1314 The factors which influence the cosmetic outcome in breast cancer patients after conservative surgery and radiotherapy Özsaran, Z.
 1997
 33 S8 p. S105-
1 p.
 artikel
1315 The human 14C5 cell substrate adhesion molecule — Expression patterns and functional activity Coene, E.
 1997
 33 S8 p. S8-S9
2 p.
 artikel
1316 The identification of high risk patients with metastatic colorectal cancer Sahmoud, T.
 1997
 33 S8 p. S166-
1 p.
 artikel
1317 The impact of vinorelblne in elderly (aged >70 years) with NSCLC: A preliminary report Mattioli, R.
 1997
 33 S8 p. S240-
1 p.
 artikel
1318 The implementation of nursing summarie Molin, C.M.
 1997
 33 S8 p. S316-
1 p.
 artikel
1319 The implication of adequate loco-regional tumor control in breast cancer — The role of adjuvant radiotherapy Overgaard, M.
 1997
 33 S8 p. S3-
1 p.
 artikel
1320 The importance of local control Rutqvist, L.E.
 1997
 33 S8 p. S216-
1 p.
 artikel
1321 The influence of healthcare culture on the implementation of nursing research findings Browne, S.E.
 1997
 33 S8 p. S331-S332
2 p.
 artikel
1322 The influence of massage and kinesitherapy on pulmonary function after a radical treatment of breast cancer Rożek-Mróz, K.
 1997
 33 S8 p. S324-
1 p.
 artikel
1323 The influence of pelvic irradiation and chemo-irradiation on the integrity of colonic anastomoses in the rat Kuzu, M.A.
 1997
 33 S8 p. S106-S107
2 p.
 artikel
1324 The Influence of previous hormone therapy on PSA response In prostate cancer patients (PTS) failing first-line androgen ablation Rassweiler, J.
 1997
 33 S8 p. S29-
1 p.
 artikel
1325 The influence of surgery on metachronous distant metastases and survival in rectal cancer Köckerling, F.
 1997
 33 S8 p. S163-
1 p.
 artikel
1326 The influence of theobromine on angiogenic activity of human ovarian cancer cells Barcz, E.
 1997
 33 S8 p. S47-
1 p.
 artikel
1327 The influence of the tumor microenvironment on malignant progression Giaccia, A.J.
 1997
 33 S8 p. S219-
1 p.
 artikel
1328 The integration of consolidation whole abdominal irradiation in the multi-modality management of advanced ovarian carcinoma: Long-term results Kuten, A.
 1997
 33 S8 p. S123-S124
2 p.
 artikel
1329 The LHRH analogue triptoreline (TAP) with or without the aromatase inhibitor formestane (4-OHA) in premenopausal advanced breast cancer: A study by the I.T.M.O. group Celio, L.
 1997
 33 S8 p. S155-
1 p.
 artikel
1330 The management of non-Hodgkin's lymphomas ANNO 1997 Hagenbeek, A.
 1997
 33 S8 p. S221-
1 p.
 artikel
1331 The management of radiation morbidity: Can nursing make a difference? Faithfull, S.
 1997
 33 S8 p. S299-
1 p.
 artikel
1332 The management of recurrent epithelial ovarian cancer Bösze, P.
 1997
 33 S8 p. S140-
1 p.
 artikel
1333 The modification of bleomycin-induced lung toxicity in a S.C.Mice model and an I.T. Rat model Dirix, L.Y.
 1997
 33 S8 p. S15-
1 p.
 artikel
1334 The multi-disciplinary team in palliative care Bird, A.
 1997
 33 S8 p. S309-
1 p.
 artikel
1335 The multidrug chemotherapy: mitomycin C (MTC), vinorelbine (VNB), carboplatin (CBPT), mitoxantrone (MTT), calcium folinate (CF), 5-fluorouracil (5-FU) in the treatment of advanced breast cancer (ABC) Szarlej-Wcislo, K.
 1997
 33 S8 p. S117-
1 p.
 artikel
1336 The nursing Advisor's role at the Norwegian cancer society's patient support center, Trondheim, Norway Bøe, Gina E.
 1997
 33 S8 p. S334-
1 p.
 artikel
1337 The nursing perspective of good quality symptom management Ambaum, E.W.C.
 1997
 33 S8 p. S72-
1 p.
 artikel
1338 The nursing trial committee: An evaluation of a model to improve nursing involvement in cancer clinical trials Ambaum, B.
 1997
 33 S8 p. S320-
1 p.
 artikel
1339 The oncology nursing in Poland: How to survive and grow in the mean of change Krasuska, M.E.
 1997
 33 S8 p. S331-
1 p.
 artikel
1340 The participation of relatives in the cancer patients care Elfving, A.B.
 1997
 33 S8 p. S303-
1 p.
 artikel
1341 The patient-generated subjective global assessment of nutritional status: Evaluation in a Swedish setting Persson, C.
 1997
 33 S8 p. S52-
1 p.
 artikel
1342 The polymorphic enzymes N-acetyltransferase 2 and glutathione S-transferase M1 In bladder cancer patients Reckwitz, T.
 1997
 33 S8 p. S31-
1 p.
 artikel
1343 The preventive effect of verapamil on radiation induced cataract: An experimental study Cengiz, M.
 1997
 33 S8 p. S108-
1 p.
 artikel
1344 The psychological implications of genetic testing in breast O’Malley, K.
 1997
 33 S8 p. S328-
1 p.
 artikel
1345 The radiologic challenge of early diagnosis in patients with breast cancer. The value of new imaging modalities for the diagnostic procedure Vogl, Th.J.
 1997
 33 S8 p. S134-
1 p.
 artikel
1346 The radiosensitivity of tumor vascular endothelial cells De Pooter, Ch.
 1997
 33 S8 p. S27-
1 p.
 artikel
1347 Therapeutic approach in stage III of cervix carcinoma Blidaru, A.
 1997
 33 S8 p. S212-S213
2 p.
 artikel
1348 Therapeutic concepts for loco-regional recurrences in soft tissue sarcomas of the extremities Klein, P.
 1997
 33 S8 p. S116-
1 p.
 artikel
1349 Therapeutic massage following mastectomy: A qualitative study of women's experience Bredin, Mary
 1997
 33 S8 p. S321-
1 p.
 artikel
1350 Therapy of cervical cancer and improvement of treatment results during the past 40 years at the gynaecological clinic of Pécs, Hungary Krommer, K.
 1997
 33 S8 p. S210-
1 p.
 artikel
1351 The relation between heat stable alkaline phosphatase isoenzyme activity and tumour regression in cervical carcinoma Kocak, Zafer
 1997
 33 S8 p. S210-
1 p.
 artikel
1352 The relationship between normal tissue radiosensitivity and radiation induced cell-cycle delays in asynchronous populations of normal fibroblasts analysed by bivariate flow cytometry Orton, C.J.
 1997
 33 S8 p. S25-
1 p.
 artikel
1353 The relationship of follow-up test results with the occurrence of overt metastatic disease Filipović, S.
 1997
 33 S8 p. S52-
1 p.
 artikel
1354 The relationship of human papillomavirus to p53 and proliferating cell nuclear antigen expression in head and neck cancer Kim, M.S.
 1997
 33 S8 p. S183-
1 p.
 artikel
1355 The relations of radiation induced ultrastructural cardiac damage with serum troponin T and creatin kinase MB levels Aslay, I.
 1997
 33 S8 p. S108-
1 p.
 artikel
1356 The Research Sister's role in the rehabilitation of cancer patients receiving infuslonal chemotherapy at home Elliott, M.E.
 1997
 33 S8 p. S324-
1 p.
 artikel
1357 The results of the accelarated fractionation scheme chart in the treatment of non-small cell lung cancer Saunders, M.I.
 1997
 33 S8 p. S286-
1 p.
 artikel
1358 The role of child life intervention in pediatric radiation oncology Propper, P.
 1997
 33 S8 p. S75-
1 p.
 artikel
1359 The role of desmosomal glycoproteins in the adhesion & invasion of human breast cancer cells Davies, E.L.
 1997
 33 S8 p. S9-
1 p.
 artikel
1360 The role of FAS-FAS-ligand(FAS-L) interaction for radiation induced apoptosis in human lymphoma cells Belka, C.
 1997
 33 S8 p. S22-
1 p.
 artikel
1361 The role of gemcitabine-induced cell cycle synchronization in radiosensitization of A SCC61 human head & neck squamous carcinoma cell (HNSCC) line Rosier, J.-F.
 1997
 33 S8 p. S23-S24
2 p.
 artikel
1362 The role of intraoperative radiotherapy in the adjuvant treatment of stage II, III rectal carcinomas Eble, M.J.
 1997
 33 S8 p. S162-
1 p.
 artikel
1363 The role of local control for soft tissue sarcoma Azzarelli, Alberto
 1997
 33 S8 p. S294-
1 p.
 artikel
1364 The role of lung function measurements before allogenic BMT to anticipate long term lung failure Beinert, Th.
 1997
 33 S8 p. S91-
1 p.
 artikel
1365 The role of neoadjuvant and adjuvant chemotherapy in non-small cell lung cancer Tonato, M.
 1997
 33 S8 p. S225-
1 p.
 artikel
1366 The role of postoperative radiotherapy in the treatment of salivary gland carcinoma's Terhaard, C.H.J
 1997
 33 S8 p. S254-
1 p.
 artikel
1367 The role of radiotherapy in esophageal cancer management Ganul, V.L.
 1997
 33 S8 p. S105-
1 p.
 artikel
1368 The role of radiotherapy in the combined treatment of stage I childhood rhabdomyosarcomas. Results of the german cooperative soft tissue sarcoma study (CWS) in 104 patients Schmidt, B.F.
 1997
 33 S8 p. S125-
1 p.
 artikel
1369 The role of scientific nurse in management of clinical trials in chemotherapy department Zarouk, V.
 1997
 33 S8 p. S330-S331
2 p.
 artikel
1370 The role of the coordinator-nurse when a new clinical trial will be introduced on the ward Svaneborg, C.J.
 1997
 33 S8 p. S335-
1 p.
 artikel
1371 The role of the nurse in palliative care Teunissen, S.C.C.M.
 1997
 33 S8 p. S222-
1 p.
 artikel
1372 The role of the palliative care specialist. Controversies and definition Ventafridda, V.
 1997
 33 S8 p. S221-
1 p.
 artikel
1373 The role of therapy in the incidence of second cancers Hawkins, M.M.
 1997
 33 S8 p. S140-
1 p.
 artikel
1374 The special problem of elderly cancer patients Monfardini, S.
 1997
 33 S8 p. S72-
1 p.
 artikel
1375 The start project: A European, evidence-based, state of the art instrument for clinical oncology Santoro, A.
 1997
 33 S8 p. S292-S293
2 p.
 artikel
1376 The suffering experiences of cancer patients with incurable illness Kuuppelomā, M.
 1997
 33 S8 p. S303-
1 p.
 artikel
1377 The surgeon and surgical procedure as a prognostic factor Northover, John
 1997
 33 S8 p. S218-
1 p.
 artikel
1378 The surgeon and surgical procedure as prognostic factor Hohenberger, W.
 1997
 33 S8 p. S71-
1 p.
 artikel
1379 The surgeon and surgical procedures as prognostic factor Bums, H.
 1997
 33 S8 p. S72-
1 p.
 artikel
1380 The surgeon as a prognostic factor in decision making in breast cancer Blichert-Toft, M.
 1997
 33 S8 p. S71-
1 p.
 artikel
1381 The surgeon as crucial factor in reducing mortality and morbidity in pancreatic resection for cancer Reber, P.U.
 1997
 33 S8 p. S71-
1 p.
 artikel
1382 The surgical management of screening detected and genetic breast cancer Holmberg, L.
 1997
 33 S8 p. S67-
1 p.
 artikel
1383 The surgical procedure and the surgeon as a prognostic factor in gastric cancer van de Velde, C.J.H.
 1997
 33 S8 p. S71-
1 p.
 artikel
1384 The theoretical nursing model applied to the care of breast cancer patients Lauri, S.
 1997
 33 S8 p. S321-
1 p.
 artikel
1385 The value of adjuvant chemotherapy in the treatment of biadder cancer Hall, A.R.
 1997
 33 S8 p. S5-
1 p.
 artikel
1386 The value of a 3-D-plannlng system for evaluation of lung dose in total body irradiation Kölbl, O.
 1997
 33 S8 p. S109-
1 p.
 artikel
1387 The value of neoadjuvant chemotherapy (NACT) after surgical-pathologic staging (SPS) vs. failed debulklng (FD) for inoperable ovarian cancer (IOC) and subsequent interventional laparotomy (ILAP) Wallwiener, D.
 1997
 33 S8 p. S123-
1 p.
 artikel
1388 The value of new prognostic factor for the prediction of disease free interval for women with primary breast cancer in comparison with histopathological variable Alex, G.
 1997
 33 S8 p. S198-
1 p.
 artikel
1389 The value of postoperative surveillance after radical surgery for colorectal cancer Daniels, M.
 1997
 33 S8 p. S166-
1 p.
 artikel
1390 The value of scintigraphy for diagnosis in differentiated thyroid cancer is questionable Weber, Th.
 1997
 33 S8 p. S273-
1 p.
 artikel
1391 The vedex regimen: An effective and well tolerated palliative treatment for non-Hodgkin's lymphoma (NHL) El-Helw, L.
 1997
 33 S8 p. S266-
1 p.
 artikel
1392 The Vienna experience with primary and adjuvant irradiation of sarcoma of the corpus uteri Knocke, T.H.
 1997
 33 S8 p. S207-
1 p.
 artikel
1393 The αvβ3 integrin as a molecular target for anticancer drug design Allman, R.
 1997
 33 S8 p. S173-
1 p.
 artikel
1394 This house beileves that extending the role of the cancer nurse compromises patient care: This author supports this argument Jodrell, N.
 1997
 33 S8 p. S336-
1 p.
 artikel
1395 This house beileves that extending the role ot the cancer nurse enhances patient care Nieweg, M.B.
 1997
 33 S8 p. S336-
1 p.
 artikel
1396 This house believes that burn-out in cancer nursing is a fallacy Voortman, D.
 1997
 33 S8 p. S315-
1 p.
 artikel
1397 This house believes that burnout in cancer nursing is a fallacy (debate session) Krcmar, C.
 1997
 33 S8 p. S315-
1 p.
 artikel
1398 Three dimensional conformal radiotherapy in the treatment of localized prostate cancer Feldmann, H.J.
 1997
 33 S8 p. S30-
1 p.
 artikel
1399 Three-dimensional treatment planning of brain gliomas: A dosimetric study of cerebral irradiation Grosu, A.L.
 1997
 33 S8 p. S200-
1 p.
 artikel
1400 Thymidylate synthase (TS) and P53 as prognostic factors for patients (PTS) with colorectal cancer (CA) treated with adjuvant 5-fluorouracil (5FU) and levamisol (LEV) Van Triest, B.
 1997
 33 S8 p. S171-
1 p.
 artikel
1401 Thyroid cancer in childhood — Value of total thyroidektomy Hoelting, Th.
 1997
 33 S8 p. S126-
1 p.
 artikel
1402 Thyroid cancer — Standards and own views Roeher, H.D.
 1997
 33 S8 p. S225-S226
2 p.
 artikel
1403 Thyroid toxicity after treatment of Hodgkin's disease Guggenberger, D.
 1997
 33 S8 p. S269-
1 p.
 artikel
1404 Time trends in survival between 1978-84 and 1985-89: Cracow cancer registry experience Pawlega, J.
 1997
 33 S8 p. S130-
1 p.
 artikel
1405 Timing of hormonal therapy in prostate cancer Mellonl, D.
 1997
 33 S8 p. S69-
1 p.
 artikel
1406 α-tocopherol (AT) antagonises the multidrug resistance reversal activity of cyclosporin A, verapamil, clofazimine and B669 van Rensburg, C.E.J.
 1997
 33 S8 p. S174-
1 p.
 artikel
1407 To 5-FU or not to 5-FU? When, how and Why to use the new active agents in advanced colorectal cancer Cvitkovic, E.
 1997
 33 S8 p. S287-S288
2 p.
 artikel
1408 Topotecan: A “compassionate use” study in patients with advanced epithelial ovarian cancer refractory to other therapies Bauknecht, T.
 1997
 33 S8 p. S120-
1 p.
 artikel
1409 Topotecan (Hycamtin™) in small cell lung cancer (SCLC) after failure of first line therapy: Multicentre phase II study von Pawel, J.
 1997
 33 S8 p. S229-
1 p.
 artikel
1410 ‘To stay what is fleeting and to enlighten what is incomprehensible’: Palliative care patients' perceptions of different approaches to making art Shaw, R.
 1997
 33 S8 p. S302-
1 p.
 artikel
1411 Total body irradiation in the treatment of myeloma by autologous bone marrow transplantation (ABMT) Maingon, P.
 1997
 33 S8 p. S102-
1 p.
 artikel
1412 Totally implantable central venous access ports connected to Groshong catheter for chemotherapy of solid tumours: Long-term results of 270 cases Biffi, R.
 1997
 33 S8 p. S57-
1 p.
 artikel
1413 Toward a theory of loss in women with breast cancer Barton Burke, M.
 1997
 33 S8 p. S302-
1 p.
 artikel
1414 Toward a theory of loss in women with breast cancer Barton Burke, M.
 1997
 33 S8 p. S62-
1 p.
 artikel
1415 Towards prediction and modulation of treatment response Bartelink, H.
 1997
 33 S8 p. S132-
1 p.
 artikel
1416 Towards prediction of radiosensitivity Begg, A.C.
 1997
 33 S8 p. S138-
1 p.
 artikel
1417 Toxicity and effect of single agent vinorelbine (V) in anthracycline-resistant metastatic breast cancer (ARMBC). Preliminary results of a phase I–II study by the danish breast cancer cooperative group (DBCG) Kjaer, M.
 1997
 33 S8 p. S147-
1 p.
 artikel
1418 Toxicity data of a multicenter, randomized study of standard FEC (FEC60) vs FEC with double epirubicin (EPI) (FEC120) plus G-CSF in metastatic breast cancer (MBC) Riccardi, A.
 1997
 33 S8 p. S157-
1 p.
 artikel
1419 Training oncologists in communication Fallowfield, L.J.
 1997
 33 S8 p. S223-
1 p.
 artikel
1420 Transcatheter embolization vs surgical ligation in the treatment of bleeding bladder neoplasms Suvorova, Y.V.
 1997
 33 S8 p. S36-
1 p.
 artikel
1421 Transcriptional regulation of protease-inhibitor maspin with tumors uppressor-activity in breast cancer Maass, N.
 1997
 33 S8 p. S7-
1 p.
 artikel
1422 Translating research findings into practice Bond, P.
 1997
 33 S8 p. S306-
1 p.
 artikel
1423 Trans-national collaboration — Cancer care and the voluntary sector Oliver, Gill
 1997
 33 S8 p. S333-
1 p.
 artikel
1424 Transplant-related morbidity (TRM) in patients undergoing bone marrow transplantation (BMT): The role of preparative regimens (PR) Giraud, Ph.
 1997
 33 S8 p. S91-
1 p.
 artikel
1425 Treatment and prognosis of male breast cancer: The Heidelberg experience Möhler, M.
 1997
 33 S8 p. S156-
1 p.
 artikel
1426 Treatment intensification with interleukln-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with small-cell lung cancer Gatzemeier, U.
 1997
 33 S8 p. S242-
1 p.
 artikel
1427 Treatment of advanced ovarian cancer (AOC) with cisplatin (P), epirubicin (E) and cyclophosphamide (C) Casal, J.
 1997
 33 S8 p. S121-
1 p.
 artikel
1428 Treatment of advanced stages of cervical cancer: Interferon alpha-2α plus isotretinoin versus radiotherapy Cardamakis, E.
 1997
 33 S8 p. S208-
1 p.
 artikel
1429 Treatment of carcinomatous meningiti (CM) with Intra-CFS sustained-release encapsulated cytarablne (DEPOCYT™) vs. Methotrexate (MTX) Glantz, M.
 1997
 33 S8 p. S199-
1 p.
 artikel
1430 Treatment of 5-fluouracil induced diarrhea using octreotide acetate Kalofonos, H.P.
 1997
 33 S8 p. S22-
1 p.
 artikel
1431 Treatment of gutaneous Kaposi's sarcoma with tin ethyl etiopurpurin (SnET2) photodynamic therapy Allison, R.
 1997
 33 S8 p. S256-S257
2 p.
 artikel
1432 Treatment of hiliar cholangiocarcinoma (Klatskin’s tumour). Our experience Lladó, L.
 1997
 33 S8 p. S279-
1 p.
 artikel
1433 Treatment of liver metastases and moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate postoperative chemotherapy: Feasibility and preliminary results Dubé, P.
 1997
 33 S8 p. S166-S167
2 p.
 artikel
1434 Treatment of malignant hipbone tumors Vedzizhev, G.M.
 1997
 33 S8 p. S117-
1 p.
 artikel
1435 Treatment of metastatic melanoma with a combination of carmustine, dacarbazine, cisplatin, tamoxifen and interferon alpha Haim, N.
 1997
 33 S8 p. S257-
1 p.
 artikel
1436 Treatment of multiple myeloma with short-term infusion of liposomal daunorubicin in combination with vincristine and dexamethason Sezer, O.
 1997
 33 S8 p. S92-
1 p.
 artikel
1437 Treatment of patients with relapsed or refractory acute myelold leukemia (AML) with recombinant engineered human anti-CD33 antibody-calicheamicin drug conjugate Slevers, E.L.
 1997
 33 S8 p. S91-
1 p.
 artikel
1438 Treatment of peripheral blood progenitor (PBPC) harvests by two-stage immunomagnetic selection: Yields comparable to positive selection alone Johnson, P.W.M.
 1997
 33 S8 p. S92-
1 p.
 artikel
1439 Treatment of recurrent and/or metastatic adeno-carclnoma of the endometrium with cisplatinum and vinorel-bine: A phase II study Gebbia, V.
 1997
 33 S8 p. S207-
1 p.
 artikel
1440 Treatment of recurrent cutaneous metastatic breast cancer with tin ethyl etiopurpurln (SnET2) photodynamic therapy Mang, T.S.
 1997
 33 S8 p. S146-S147
2 p.
 artikel
1441 Treatment of relapsing and refractory non-Hodgkin's lymphoma with a combination of dexamethasone, Ara-C, ifosfamide and cisplatin (DAIP) Haim, N.
 1997
 33 S8 p. S269-
1 p.
 artikel
1442 Treatment of resistant choriocarcinoma of the uterus Toloknov, B.O.
 1997
 33 S8 p. S209-
1 p.
 artikel
1443 Treatment response in childhood rhabdomyosarcoma (RMS) related to apoptotic and proliferation fraction Ball, L.M.
 1997
 33 S8 p. S114-
1 p.
 artikel
1444 Treatment results of synovial sarcoma Koçak, Zafer
 1997
 33 S8 p. S116-
1 p.
 artikel
1445 Treatment-tolerance of HIV-infected patients with anal-cancer to radiotherapy and radiochemotherapy Höcht, St.
 1997
 33 S8 p. S106-
1 p.
 artikel
1446 Trimetrexate (TMTX) modulation of 5-fluorouracil/leucovorin (5-FU/LCV) in untreated head and neck cancer Cvitkovic, F.
 1997
 33 S8 p. S191-
1 p.
 artikel
1447 Troplsetron for prophylaxis of chemotherapy-induced emesis. Results of a German multicenter study Drechsler, S.
 1997
 33 S8 p. S56-S57
2 p.
 artikel
1448 True hyperthermic antiblastic limb perfusion for stage I melanoma: An appraisal of survival gain Sellacci, A.
 1997
 33 S8 p. S258-
1 p.
 artikel
1449 Tumor cell detection in breast cancer patients before and after neoadjuvant chemotherapy Solomaver, E.-F.
 1997
 33 S8 p. S79-S80
2 p.
 artikel
1450 Tumor circulating cells in low-risk breast cancer patients Ferrara, F.
 1997
 33 S8 p. S10-
1 p.
 artikel
1451 Tumor lymphocytic infiltration, hormonal-metabolic status and aromatase gene expression in breast cancer Berstein, L.
 1997
 33 S8 p. S10-
1 p.
 artikel
1452 Tumor prosthesis in bone sarcomas Mercun, M
 1997
 33 S8 p. S142-
1 p.
 artikel
1453 Tumor regression during external radiotherapy as a predictive factor of local control in glottic cancer Szutkowski, Z.
 1997
 33 S8 p. S105-
1 p.
 artikel
1454 Tumor tissue pO2, S-phase-fraction, p53-status and response to radiotherapy in cervical cancers Hänsgen, Gabriele
 1997
 33 S8 p. S100-S101
2 p.
 artikel
1455 Tumor uptake of MTX-albumin conjugates in rats Stehle, G.
 1997
 33 S8 p. S180-
1 p.
 artikel
1456 Tumour hypoxia and treatment outcome Lartigau, E.
 1997
 33 S8 p. S219-
1 p.
 artikel
1457 Tumour specific antigens: Perspectives for vaccination Coulie, P.G.
 1997
 33 S8 p. S288-
1 p.
 artikel
1458 Types of diet and breast cancer risk among native and immigrant females in upper Silesla region, Poland Zemla, B.
 1997
 33 S8 p. S130-
1 p.
 artikel
1459 Types of failures after concomitant radio-chemotherapy and "boost in field" with or without surgery for locally advanced cervix cancer Nagy, V.
 1997
 33 S8 p. S209-
1 p.
 artikel
1460 Unusual distribution of HLA-DRB alleles in tumour patients Lyshchov, Anton A.
 1997
 33 S8 p. S13-S14
2 p.
 artikel
1461 Unwanted effects of evening primrose oll on tumor angiogenesis and blood granulocyte number Sommer, E.
 1997
 33 S8 p. S47-
1 p.
 artikel
1462 Update on ductal carcinoma in situ trials Julien, J.P.
 1997
 33 S8 p. S67-S68
2 p.
 artikel
1463 Update on recent developments in cancer pain management De Conno, F.
 1997
 33 S8 p. S143-
1 p.
 artikel
1464 Use DNA flow cytometry (DNA FCM) in diagnosis and prog.nosis of serous boderline tumors and high grade ovarian cancer Panitchenko, I.V.
 1997
 33 S8 p. S124-
1 p.
 artikel
1465 Useful or useless? B-scan sonography of malignant cervical lymph nodes during primary radiotherapy (RT) for squamous cell carcinoma of the head and neck Schäfer, C.B.
 1997
 33 S8 p. S193-
1 p.
 artikel
1466 Use of Tc-99 labelled colloidal albumin for preoperative and intraoperative localization of non-palpable breast lesions Galimberti, V.
 1997
 33 S8 p. S79-
1 p.
 artikel
1467 Use of the delta assay of plastic adherent progenitors (PD) to measure early haemopoietic precursors in peripheral blood harvests Adams, J.
 1997
 33 S8 p. S94-S95
2 p.
 artikel
1468 Uterine leiomyosarcomas conservative treated and following pregnancies Friedrich, M.
 1997
 33 S8 p. S213-
1 p.
 artikel
1469 Uveal melanoma (UM) I. 125 brachytherapy: Indications, technique and preliminary result Petrlz, L.
 1997
 33 S8 p. S259-S260
2 p.
 artikel
1470 Vaccination against lung cancer: Animal models Eisenbach, Lea
 1997
 33 S8 p. S288-
1 p.
 artikel
1471 Vaccination of colorectal and pancreatic cancer patients with baculovirus-derived extracellular domain of GA733 antigen Staib, L.
 1997
 33 S8 p. S85-
1 p.
 artikel
1472 Vaccination with GM-CSF transduced melanoma cells: A promising treatment Rankin, E.M.
 1997
 33 S8 p. S135-S136
2 p.
 artikel
1473 Value and indications of surgery in locally advanced breast cancers Nos, C.
 1997
 33 S8 p. S216-
1 p.
 artikel
1474 Variability in systemic availability of the 5-HT3 receptor antagonist anti-emetics Ondansetron (Ond) and Gramsetron (Gran) following oral administration Palmer, J.L.
 1997
 33 S8 p. S58-
1 p.
 artikel
1475 Variations in cancer outcome in Europe Berrino, F.
 1997
 33 S8 p. S285-
1 p.
 artikel
1476 Vascular endothelial growth factors and receptors involved in angiogenesis and lymphangiogenesis Alitalo, Kari
 1997
 33 S8 p. S224-
1 p.
 artikel
1477 VEGF expression as a prognostic factor in node-positive esophageal cancer Ogata, Y.
 1997
 33 S8 p. S51-
1 p.
 artikel
1478 Venous invasion as a prognostic factor in colorectal carcinoma Moutinho-Ribeiro, M.
 1997
 33 S8 p. S163-S164
2 p.
 artikel
1479 Vesnarinone inhibits growth of small cell lung cancer cell lines via induction of apoptosis Yamaguchi, A.
 1997
 33 S8 p. S231-
1 p.
 artikel
1480 Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial Pirker, R.
 1997
 33 S8 p. S252-
1 p.
 artikel
1481 Vinorelbine (VRL) in patients with recurrent multiple myeloma (MM): A phase II study Harousseau, J.L.
 1997
 33 S8 p. S90-
1 p.
 artikel
1482 Weekly fractionated paclitaxel in metastatic breast cancer — Dose optimising study Lültner, S.
 1997
 33 S8 p. S156-
1 p.
 artikel
1483 Weekly high dose cisplatin (P) and daily oral vepesid (VP): A highly active salvage regimen for progressive or recurrent ovarian cancer after platinum therapy van der Burg, M.E.L.
 1997
 33 S8 p. S118-S119
2 p.
 artikel
1484 Weekly paclitaxe/carboplatin and radiotherapy in inoperable squamous cell carcinoma of head & neck and lung Schmidt, P.
 1997
 33 S8 p. S194-
1 p.
 artikel
1485 Weekly treatment of non-small-cell lung (NSCLC) cancer patients with paclitaxel (P) and carboplatin (C) Schroeder, M.
 1997
 33 S8 p. S235-
1 p.
 artikel
1486 Well differentiated thyroid cancer: Analysis of survival for 299 operated patients Andry, G.
 1997
 33 S8 p. S273-
1 p.
 artikel
1487 What are the indicators of quality cancer care? Luthert, J.M.
 1997
 33 S8 p. S338-
1 p.
 artikel
1488 What have we learnt during 60 years of surgery for pancreatic cancer Andrén-Sandberg, Å.
 1997
 33 S8 p. S225-
1 p.
 artikel
1489 What's up doc? — A patient's perspective on Doctor/patient communication H. Gold, Stephen
 1997
 33 S8 p. S222-
1 p.
 artikel
1490 Where do patients seek additional information after a diagnosis of cancer — A multicentre survey? Shingler, G.
 1997
 33 S8 p. S321-
1 p.
 artikel
1491 Withholding or withdrawing (artificial) nutrition and/or hydration from patients terminally III with malignancy: Under what circumstances (if any) is it morally justified? Mula, C.
 1997
 33 S8 p. S303-
1 p.
 artikel
                             1491 gevonden resultaten
 
<< vorige   
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland